Home/Filings/3/0001578563-24-000079
3//SEC Filing

BAYER AKTIENGESELLSCHAFT 3

Accession 0001578563-24-000079

CIK 0001785279other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 5:03 PM ET

Size

14.0 KB

Accession

0001578563-24-000079

Insider Transaction Report

Form 3
Period: 2024-02-08
Holdings
  • Series A-1 Convertible Preferred Stock

    Common Stock (1,770,888 underlying)
  • Series A-4 Convertible Preferred Stock

    Common Stock (1,180,592 underlying)
  • Series B Convertible Preferred Stock

    Common Stock (589,662 underlying)
  • Series B-1 Convertible Preferred Stock

    Common Stock (509,855 underlying)
Footnotes (5)
  • [F1]Each share of Series A-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Each share of Series A-1 Convertible Preferred Stock has no expiration date.
  • [F2]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.
  • [F3]Each share of Series A-4 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series A-4 Convertible Preferred Stock has no expiration date.
  • [F4]Each share of Series B Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date.
  • [F5]Each share of Series B-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B-1 Convertible Preferred Stock has no expiration date.

Issuer

Metagenomi, Inc.

CIK 0001785279

Entity typeother

Related Parties

1
  • filerCIK 0001144145

Filing Metadata

Form type
3
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:03 PM ET
Size
14.0 KB